Cargando…

Endometriosis-targeted MRI imaging using bevacizumab-modified nanoparticles aimed at vascular endothelial growth factor

Endometriosis is a tumor-like disease with high recurrence. In this case, the accurate imaging-based diagnosis of endometriosis can help clinicians eradicate it by improving their surgical plan. However, although contrast agents can improve the visibility of the tissue of interest in vivo via magnet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Qi, Wu, Shiman, Li, Yajie, Lai, Mao, Li, Qing, Fu, Caixia, Yao, Zhenwei, Zhang, Junhai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	RSC 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10367955/ https://www.ncbi.nlm.nih.gov/pubmed/37496625 http://dx.doi.org/10.1039/d2na00787h

Ejemplares similares

Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
por: Nagai, Toshihiro, et al.
Publicado: (2014)

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI
por: Guo, J, et al.
Publicado: (2015)

Serum and Peritoneal Fluid Levels of Vascular Endothelial Growth Factor in Women with Endometriosis
por: Kianpour, Maryam, et al.
Publicado: (2013)

Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells
por: Brar, Vikram S., et al.
Publicado: (2010)

Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
por: Wang, Donghyun, et al.
Publicado: (2014)

Genetic polymorphisms of Vascular Endothelial Growth Factor (VEGF) associated with endometriosis in Nigerian women
por: Babah, Ochuwa Adiketu, et al.
Publicado: (2021)

Hyaluronic Acid-Modified Magnetic Iron Oxide Nanoparticles for MR Imaging of Surgically Induced Endometriosis Model in Rats
por: Zhang, He, et al.
Publicado: (2014)

Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway
por: Wang, Cuiju, et al.
Publicado: (2021)

Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011)

Concentration of Vascular Endothelial Growth Factor After Intracameral Bevacizumab Injection in Eyes With Neovascular Glaucoma
por: Lim, Tae Hoon, et al.
Publicado: (2009)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells
por: Jun, Jong Hwa, et al.
Publicado: (2016)

A Novel Angiogenesis Inhibitor Bevacizumab Induces Apoptosis in the Rat Endometriosis Model
por: Soysal, D, et al.
Publicado: (2015)

Methodological Concerns Regarding Levels of Vascular Endothelial Growth Factor (VEGF) in Serum of Women with Endometriosis
por: Leone Roberti Maggiore, Umberto, et al.
Publicado: (2015)

The Association Analysis of Vascular Endothelial Growth Factor -2549 Insertion/ Deletion Variant and Endometriosis Risk
por: Sarhangi, Negar, et al.
Publicado: (2019)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer
por: Weickhardt, A J, et al.
Publicado: (2015)

Bevacizumab‐enhanced antitumor effect of 5‐fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2‐specificity protein 1 pathway
por: Liu, Wenyue, et al.
Publicado: (2018)

Bladder Endometriosis: Ultrasound and MRI Findings
por: Beaty, Sean D., et al.
Publicado: (2015)

MRI in the Diagnosis of Endometriosis and Related Diseases
por: Kido, Aki, et al.
Publicado: (2022)

Association of Vascular Endothelial Growth Factor (VEGF) +405 G>C Polymorphism with Endometriosis in an Iranian Population
por: Memariani, Toktam, et al.
Publicado: (2010)

Effect of mistletoe on endometrial stromal cell survival and vascular endothelial growth factor expression in patients with endometriosis
por: Moon, Jeong Min, et al.
Publicado: (2018)

Shear stress regulation of nanoparticle uptake in vascular endothelial cells
por: Zhang, Hongping, et al.
Publicado: (2023)

Influence of vascular endothelial growth factor inhibition on simple renal cysts in patients receiving bevacizumab-based chemotherapy
por: Grenader, Tal, et al.
Publicado: (2015)

Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma
por: Amano, Takahiro, et al.
Publicado: (2021)

Role of Bevacizumab on Vascular Endothelial Growth Factor in Apolipoprotein E Deficient Mice after Traumatic Brain Injury
por: Genovese, Tiziana, et al.
Publicado: (2022)

Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model
por: Abuohashish, Hatem, et al.
Publicado: (2023)

Transforming Growth Factor-beta 1 Involved in the Pathogenesis of Endometriosis through Regulating Expression of Vascular Endothelial Growth Factor under Hypoxia
por: Yu, Yue-Xin, et al.
Publicado: (2017)

Effect of PARP Inhibitor Combined with Bevacizumab on Platinum-Resistant Recurrent Ovarian Epithelial Carcinoma
por: Sun, Li, et al.
Publicado: (2022)

Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair
por: Nagai, Toshihiro, et al.
Publicado: (2010)

Detection of vascular endothelial growth factor in colon cancer xenografts using bevacizumab based near infrared fluorophore conjugate
por: Paudyal, Bishnuhari, et al.
Publicado: (2014)

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
por: Al-Debasi, Tariq, et al.
Publicado: (2017)

Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis
por: Machado, Daniel Escorsim, et al.
Publicado: (2015)

Reciprocal regulation of NRF2 by autophagy and ubiquitin–proteasome modulates vascular endothelial injury induced by copper oxide nanoparticles
por: Li, Na, et al.
Publicado: (2022)

Study on the Mechanism of the Reversible Color Change of Polyacrylic Acid Modified Gold Nanoparticles Responding to pH
por: Li, Runmei, et al.
Publicado: (2021)

Ferritinophagy is involved in the zinc oxide nanoparticles-induced ferroptosis of vascular endothelial cells
por: Qin, Xia, et al.
Publicado: (2021)

Anti‐bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor‐binding response, impairing tumor outgrowth
por: Sanches, Jéssica de Souza, et al.
Publicado: (2016)

Anti-Vascular Endothelial Growth Factor (Bevacizumab) Therapy Reduces Hypertrophic Scar Formation in a Rabbit Ear Wounding Model
por: Kwak, Do Hoon, et al.
Publicado: (2016)

CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA
por: Hirano, Takao, et al.
Publicado: (2018)

The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis
por: Ruan, Guanyu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ibb2ta2vriolrnhr95dlpgfc4r